Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	113.31	3.65	40.96	20.08	15.98
Revenue Growth (YoY)	3005.10%	-91.09%	104.03%	25.61%	10.89%
Gross Profit	113.31	3.65	40.96	20.08	15.98
Selling, General & Admin	51.29	50.51	46.11	42.51	48.87
Research & Development	130.01	115.86	121.88	130.94	175.43
Operating Expenses	181.3	166.37	167.98	173.45	224.3
Operating Income	-68	-162.72	-127.02	-153.38	-208.32
Other Expense / Income	-9.81	-1.58	-4.57	-2.63	-14.68
Pretax Income	-58.19	-161.14	-122.45	-150.75	-193.64
Income Tax	-0.68	0.68	-0.2	-0.84	0
Net Income	-57.51	-161.82	-122.25	-149.91	-193.64
Shares Outstanding (Basic)	106	79	52	39	34
Shares Outstanding (Diluted)	106	79	52	39	34
Shares Change	34.55%	52.16%	32.11%	15.83%	16.90%
EPS (Basic)	-0.54	-2.05	-2.36	-3.82	-5.72
EPS (Diluted)	-0.54	-2.05	-2.36	-3.82	-5.72
Free Cash Flow	-20.55	-129.04	-89.55	-117.32	-192.15
Free Cash Flow Per Share	-0.19	-1.64	-1.73	-2.99	-5.67
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-60.01%	-4459.30%	-310.07%	-763.94%	-1303.37%
Profit Margin	-50.76%	-4434.72%	-298.42%	-746.68%	-1211.52%
Free Cash Flow Margin	-18.13%	-3536.20%	-218.61%	-584.35%	-1202.21%
EBITDA	-48.98	-151.03	-112.61	-140.77	-184.44
EBITDA Margin	-43.23%	-4138.89%	-274.91%	-701.14%	-1153.96%
Depreciation & Amortization	9.21	10.11	9.84	9.98	9.2
EBIT	-58.19	-161.14	-122.45	-150.75	-193.64
EBIT Margin	-51.36%	-4416.06%	-298.92%	-750.86%	-1211.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).